Other observed topics

inflammatory bowel

Observed in 164 articles across 16 journals.

Falling

Latest share0.30%

Change vs baseline-0.44 pp

Months observed12

Latest monthJul 2026

Portfolio article share

Attention over this snapshot

13 monthly points

Journal breadth

Where it appears

Frontline Gastroenterology63
Gut55
BMJ Open Gastroenterology15
BMJ Open9
European Journal of Hospital Pharmacy6
BMJ Case Reports3
Archives of Disease in Childhood2
BMJ2
BMJ Open Quality2
BMJ Paediatrics Open1
Drug and Therapeutics Bulletin1
eGastroenterology1

Co-occurrence

Explore nearby topics

Inspect the source signal

Article evidence

30 high-ranking examples

Frontline Gastroenterology · 2026-07-15

‘We need to highlight as a community that these are avoidable’: exploring clinician perspectives on healthcare access and avoidable admissions in inflammatory bowel disease

Phrase rank #2 · DOI 10.1136/flgastro-2026-103675

BMJ Open Gastroenterology · 2026-07-13

Selective COX-2 inhibitors for short-term musculoskeletal pain in inflammatory bowel disease in remission: a narrative review

Phrase rank #2 · DOI 10.1136/bmjgast-2026-002316

Frontline Gastroenterology · 2026-06-29

OC80 Usefulness of age-banded patient information leaflets to support healthcare transition for young people with inflammatory bowel disease

Phrase rank #2 · DOI 10.1136/flgastro-2026-bspghan.69

Frontline Gastroenterology · 2026-06-29

OC43 The successful use of infliximab in a 3-month-old infant with non-monogenic inflammatory bowel disease

Phrase rank #2 · DOI 10.1136/flgastro-2026-bspghan.32

Frontline Gastroenterology · 2026-06-29

LBA12 Chemosensory dysfunction in inflammatory bowel disease: a systematic review of olfactory and gustatory impairment

Phrase rank #2 · DOI 10.1136/flgastro-2026-bspghan.111

Gut · 2026-06-23

P240 Gender identity and inflammatory bowel disease: a retrospective bioresource cohort study

Phrase rank #2 · DOI 10.1136/gutjnl-2026-BSG.360

Gut · 2026-06-23

P183 Prevalence and associated risk factors of erectile dysfunction among patients with inflammatory bowel disease: an updated systematic review meta-analysis

Phrase rank #2 · DOI 10.1136/gutjnl-2026-BSG.309

Frontline Gastroenterology · 2026-05-28

Systematic review and meta-analysis of glucagon-like peptide 1 receptor agonists (GLP1-RAs) safety and efficacy in patients with inflammatory bowel disease

Phrase rank #2 · DOI 10.1136/flgastro-2026-103640

BMJ Open · 2026-05-26

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Phrase rank #2 · DOI 10.1136/bmjopen-2025-115709

Frontline Gastroenterology · 2026-04-22

Pregnancy outcomes in women with inflammatory bowel disease requiring hospitalisation: a retrospective cohort study

Phrase rank #2 · DOI 10.1136/flgastro-2026-103612

BMJ Paediatrics Open · 2026-01-19

Limited willingness to switch from intravenous to subcutaneous treatment in paediatric inflammatory bowel disease

Phrase rank #2 · DOI 10.1136/bmjpo-2025-004020

BMJ Open Gastroenterology · 2025-12-25

MOdel-informed precision dosing (MIPD) of ustekinumab and VEdolizumab in inflammatory bowel disease: protocol for an Independent randomised, controlled, multicentre Trial (MOVE-IT)

Phrase rank #2 · DOI 10.1136/bmjgast-2025-001985

Frontline Gastroenterology · 2025-12-05

ESPEN guideline on clinical nutrition in inflammatory bowel disease: a guideline review

Phrase rank #2 · DOI 10.1136/flgastro-2025-103062

BMJ Open Quality · 2025-10-22

Adherence to a care pathway for inflammatory bowel disease in the southwest region of the Netherlands: results of a mixed-methods implementation study

Phrase rank #2 · DOI 10.1136/bmjoq-2025-003583

Frontline Gastroenterology · 2025-10-05

Developing a discriminatory pathway for colorectal cancer and inflammatory bowel disease in the young: a pilot study

Phrase rank #2 · DOI 10.1136/flgastro-2025-103269

Frontline Gastroenterology · 2025-09-22

Inflammatory bowel disease–dermatology: evaluation of a collaborative, multidisciplinary, patient-centred care model

Phrase rank #2 · DOI 10.1136/flgastro-2025-103327

Frontline Gastroenterology · 2025-08-20

OC60 Postal faecal calprotectin testing: a qualitative study assessing impact of a pilot on patient and carer experience in a paediatric inflammatory bowel disease (PIBD) population

Phrase rank #2 · DOI 10.1136/flgastro-2025-bspghan.60

Frontline Gastroenterology · 2025-08-20

OC59 Is adrenal insufficiency a risk in children with inflammatory bowel disease treated with systemic steroids? Our experience interpreted through NICE guideline

Phrase rank #2 · DOI 10.1136/flgastro-2025-bspghan.59

Gut · 2025-08-07

Challenge of treatment de-escalation in inflammatory bowel diseases

Phrase rank #2 · DOI 10.1136/gutjnl-2024-334358

Frontline Gastroenterology · 2025-08-01

Patients with inflammatory bowel disease are at an increased risk of venous thromboembolism for up to 30 days following hospitalisation: a systematic review and meta-analysis

Phrase rank #2 · DOI 10.1136/flgastro-2025-103263

BMJ Open Gastroenterology · 2026-07-01

Digital self-management programme for pain, fatigue and faecal incontinence in inflammatory bowel disease: cost-effectiveness analysis of the IBD-BOOST randomised controlled trial

Phrase rank #3 · DOI 10.1136/bmjgast-2025-002140

Frontline Gastroenterology · 2026-06-29

OC104 Multi-centre review of transitional care in young adults with paediatric-onset inflammatory bowel disease

Phrase rank #3 · DOI 10.1136/flgastro-2026-bspghan.93

Frontline Gastroenterology · 2026-06-29

LBA14 Single-centre experience with upadacitinib in children with anti-TNF failure inflammatory bowel disease

Phrase rank #3 · DOI 10.1136/flgastro-2026-bspghan.113

Gut · 2026-06-26

IDDF2026-ABS-0430 Gut volatile metabolites as functional markers of chronic intestinal inflammation

Phrase rank #3 · DOI 10.1136/gutjnl-2026-IDDF.346

Gut · 2026-06-23

P204 More than the gut: psychological morbidity and demand for integrated care in inflammatory bowel disease

Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.327

Gut · 2026-06-23

P233 Epidemiology and characteristics of adult patients with inflammatory bowel disease ineligible for anti-tumour necrosis factor treatment: real-world evidence from REFINE

Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.354

Gut · 2026-06-23

P244 Clinical outcomes of vedolizumab withdrawal in inflammatory bowel disease patients

Phrase rank #3 · DOI 10.1136/gutjnl-2026-BSG.363

Frontline Gastroenterology · 2026-06-19

Management of neoplasia in inflammatory bowel disease

Phrase rank #3 · DOI 10.1136/flgastro-2026-103741

Evidence Based Nursing · 2026-05-11

Association between inflammatory bowel disease and coeliac disease in children

Phrase rank #3 · DOI 10.1136/ebnurs-2025-104396

Frontline Gastroenterology · 2026-04-08

Access to intestinal ultrasound influences diagnostic decision-making, reduces healthcare costs and improves sustainability in inflammatory bowel disease

Phrase rank #3 · DOI 10.1136/flgastro-2025-103577